AR012109A1 - DERIVATIVES OF BENZENOSULFONAMIDE, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITION - Google Patents

DERIVATIVES OF BENZENOSULFONAMIDE, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITION

Info

Publication number
AR012109A1
AR012109A1 ARP980101236A ARP980101236A AR012109A1 AR 012109 A1 AR012109 A1 AR 012109A1 AR P980101236 A ARP980101236 A AR P980101236A AR P980101236 A ARP980101236 A AR P980101236A AR 012109 A1 AR012109 A1 AR 012109A1
Authority
AR
Argentina
Prior art keywords
group
benzenosulfonamide
therapeutics
derivatives
preparation
Prior art date
Application number
ARP980101236A
Other languages
Spanish (es)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of AR012109A1 publication Critical patent/AR012109A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/47—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compuesto de la formula (I) en la cual: A representa un átomo de hidrogeno, un halogeno tal como el fluor, el coloro o el bromo, un grupo ciano, un grupoC1-4 alquilo o un grupo alcoxi; R1 y R2 idénticos o diferentes, repesentan cada uno un átomo de hidrogeno, un grupo C1-C6 alquilo, un grupo C2-6 alquenilo o R1y R2 forman juntos una cadena C2-6 alquileno o C2-6 alquenileno y R3 representa un átomo de hidrogeno o un grupo C1-4 alquilo con la exclusion del clorhidratode 3-bencenosulfonamidoguanidina. Aplicacion en terapéutica.Compound of formula (I) in which: A represents a hydrogen atom, a halogen such as fluorine, color or bromine, a cyano group, a C1-4alkyl group or an alkoxy group; R1 and R2 are identical or different, each representing a hydrogen atom, a C1-C6 alkyl group, a C2-6 alkenyl group or R1 and R2 together form a C2-6 alkylene or C2-6 alkenylene chain and R3 represents an atom of hydrogen or a C1-4 alkyl group with the exclusion of 3-benzenesulfonamidoguanidine hydrochloride. Therapeutic application.

ARP980101236A 1997-03-20 1998-03-19 DERIVATIVES OF BENZENOSULFONAMIDE, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITION AR012109A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9703394A FR2761061B1 (en) 1997-03-20 1997-03-20 BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
AR012109A1 true AR012109A1 (en) 2000-09-27

Family

ID=9505005

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980101236A AR012109A1 (en) 1997-03-20 1998-03-19 DERIVATIVES OF BENZENOSULFONAMIDE, ITS PREPARATION, ITS APPLICATION IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITION

Country Status (6)

Country Link
EP (1) EP0971900A1 (en)
AR (1) AR012109A1 (en)
AU (1) AU6924198A (en)
FR (1) FR2761061B1 (en)
WO (1) WO1998042679A1 (en)
ZA (1) ZA982358B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323231B1 (en) 2000-02-17 2001-11-27 Abbott Laboratories Use of α1A adrenoceptor agonists with α1B and α1D antagonism for the treatment of stress urinary incontinence
DE10106214A1 (en) * 2001-02-10 2002-08-14 Boehringer Ingelheim Pharma New alkyl-phenylimino-imidazolidine derivatives for the treatment of urinary incontinence

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2456731A1 (en) * 1979-05-16 1980-12-12 Choay Sa Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activity
FR2549049B1 (en) * 1983-07-13 1986-06-20 Chauvin Blache Lab NEW AMIDINES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines
FR2737494B1 (en) * 1995-08-04 1997-08-29 Synthelabo BENZENESULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Also Published As

Publication number Publication date
ZA982358B (en) 1998-09-22
AU6924198A (en) 1998-10-20
WO1998042679A1 (en) 1998-10-01
EP0971900A1 (en) 2000-01-19
FR2761061B1 (en) 1999-04-23
FR2761061A1 (en) 1998-09-25

Similar Documents

Publication Publication Date Title
PE20030188A1 (en) CAST RING COMPOUND AS HEPATITIS C VIRUS POLYMERASE INHIBITORS
AR021534A1 (en) DERIVATIVES OF 1,4-DIAZABICICLO [3.2.2] NONANO, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
AR025276A1 (en) THE USE OF A COMPOUND THAT IS A DERIVATIVE OF 2-AMINO-1,3-TIAZOL, A COMPOUND THAT IS A DERIVATIVE OF 2-AMINO-1,3-TIAZOL, A PROCEDURE TO PRODUCE IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
AR033735A1 (en) ALFA-AMINO ACIDS COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE302775T1 (en) CARBOLINE DERIVATIVES
ECSP034444A (en) DERIVATIVES OF 4-AMINO-6-PHENYL-PIRROLO (2,3-D) PYRIMIDINE
PE20040684A1 (en) BENZIMIDAZOLE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS
AR054799A1 (en) OXINDOL DERIVATIVES
HUP0202263A2 (en) Benzimidazole, indole and imidazo-pyridine derivatives and pharmaceutical compositions containing them
EA200100992A1 (en) IMPDH ENZYME INHIBITORS
TR200201874T2 (en) New compounds and compositions as protease inhibitors.
ECSP12006640A (en) ASPARTIL PROTEASA HETEROCYCLIC INHIBITORS
BRPI0417717A (en) compound, pharmaceutical composition, and use of a compound
PE20090276A1 (en) COMPOUNDS DERIVED FROM IMIDAZOQUINOLINE AS MODULATORS OF TLR7
EA200200480A1 (en) ORAL COMPOSITIONS OF ANTI-TUMOR COMPOUNDS
ATE346067T1 (en) CARBOLINE DERIVATIVES
HUP0002510A2 (en) Tetrazole derivatives and pharmaceutical compositions containing them
ATE299142T1 (en) PHENYLPIPERAZINE DERIVATIVES AS SEROTONIN REUPPOST INHIBITORS
TR200402529T4 (en) New Phenylyloxy phenyl derivatives.
DK1097173T3 (en) Use of IL-2 peptides and derivatives thereof as therapeutic agents
AR027296A1 (en) DERIVATIVES OF 4-HETEROARIL-1,4-DIAZABICICLO [3.2.2] NONANO, ITS PREPARATION AND THERAPEUTIC APPLICATION
CO5601021A2 (en) DERIVATIVES OF QUINAZOLINONA, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR PREPARATION PROCESS AND ITS USE AS ANTAGONISTS CB
ATE359791T1 (en) PYRIMIDINE-2,4-DIONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS
AR022824A1 (en) DIHETERO-REPLACED METALOPROTEASE INHIBITORS
AR013503A1 (en) A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A SELECTIVE H5-HT (1B) ANTAGONIST OR PARTIAL AGONIST, PHARMACEUTICAL FORMULATION, USES AND PREPARATION METHOD